United States — Food and Drug Administration & Marty Makary
21 shared events · Importance 14 · Last updated May 17, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing a leadership change with the resignation of its Commissioner, Marty Makary, and the appointment of Kyle Diamantas as acting chief. The agency has faced internal clashes, policy confusion, and criticism during Marty Makary's tenure.
Marty Makary: Marty Makary resigned as Commissioner of the United States — Food and Drug Administration (FDA) due to disagreements with President Donald Trump over policy decisions, particularly regarding flavored e-cigarettes and abortion medication. His departure marks the end of a tumultuous 13-month tenure.
May 08, 2026 · 35 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration experienced significant leadership turnover, low staff morale, and unpredictable regulatory shifts under Marty Makary's leadership, leading to uncertainty for regulated industries.
Marty Makary: Marty Makary resigned as the head of the United States — Food and Drug Administration (FDA) after a tumultuous tenure marked by internal conflicts and external criticism from various interest groups.
May 12, 2026 · 32 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration>>> is the agency undergoing a significant leadership change with the planned ouster of its Commissioner Marty Makary>>>, which has led to low morale and high-profile departures.
Marty Makary: Marty Makary>>> is the current FDA Commissioner whose firing is being planned by the White House due to various controversies and criticisms regarding his leadership and decisions.
May 08, 2026 · 7 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration is undergoing a leadership change with Marty Makary's resignation and Kyle Diamantas taking over as acting commissioner, potentially signaling shifts in regulatory policy.
Marty Makary: Marty Makary resigned as Commissioner of the United States — Food and Drug Administration amidst reports of being fired due to disagreements over abortion pill policy and flavored vaping products.
May 12, 2026 · 8 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration launched Elsa 4.0 and consolidated data into HALO, significantly modernizing its operations and enhancing its ability to review and approve medical products.
Marty Makary: Marty Makary, as the Commissioner of the United States — Food and Drug Administration, championed the modernization initiative, emphasizing the importance of AI tools for staff efficiency and scientific focus.
May 06, 2026 · 7 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration is undergoing a significant shake-up with the departure of key officials like Tracy Beth Høeg and Marty Makary, and the United States — White House exerting more control over its policies.
Marty Makary: Marty Makary, the former Commissioner of the United States — Food and Drug Administration, resigned, triggering a broader shake-up within the agency and leading to the expected departure of other officials he appointed.
May 15, 2026 · 6 articles
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing significant leadership changes, including the removal of Tracy Beth Høeg and the resignation of Marty Makary and Vinay Prasad, which could impact its regulatory direction and stability.
Marty Makary: Marty Makary resigned as United States — Food and Drug Administration Commissioner, having engineered Tracy Beth Høeg's rapid rise and facing criticism from political allies.
May 16, 2026 · 10 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration faces a leadership void after Marty Makary's resignation, leaving unfinished initiatives and ongoing reviews under scrutiny. Its ability to balance regulatory interests with new health policies is challenged.
Marty Makary: Marty Makary resigned as head of the United States — Food and Drug Administration, widening the leadership gap within the United States — United States Department of Health and Human Services and leaving behind unfinished initiatives.
May 13, 2026 · 6 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration was directed by Donald Trump to issue new guidance on acetaminophen and approved leucovorin for autism treatment, facing scrutiny for its scientific basis.
Marty Makary: Marty Makary, the United States — Food and Drug Administration Commissioner, announced the agency's actions regarding acetaminophen and leucovorin under the Trump administration's directive.
Sep 22, 2025 · 6 articles
Domestic
United States — Food and Drug Administration: The United States — Food and Drug Administration is expected to notify doctors about a potential association between acetaminophen and autism, a recommendation that lacks immediate medical evidence and is controversial.
Marty Makary: Marty Makary, as United States — Food and Drug Administration Commissioner, announced steps to approve leucovorin as a treatment option for patients with low folate levels, potentially including some with autism.
Sep 22, 2025 · 6 articles
International
United States — Food and Drug Administration: Marty Makary is resigning as head of the United States — Food and Drug Administration after facing complaints from various groups and internal staff.
Marty Makary: Marty Makary is resigning as the head of the United States — Food and Drug Administration due to difficulties and complaints from health industry executives, anti-abortion activists, and other Trump allies.
May 12, 2026 · 9 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing leadership changes with Dr. Marty Makary's resignation and Kyle Diamantas taking over as acting commissioner.
Marty Makary: Marty Makary resigned as the head of the United States — Food and Drug Administration after a rocky tenure and complaints from various industry groups.
May 13, 2026 · 6 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration experienced leadership shake-ups, with its top drug official, Dr. Tracy Beth Høeg, being fired and Commissioner Marty Makary resigning.
Marty Makary: Marty Makary resigned as the United States — Food and Drug Administration Commissioner, contributing to the agency's leadership upheavals.
May 16, 2026 · 7 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing leadership changes with the resignation of Marty Makary, leading to uncertainty about the fate of various initiatives.
Marty Makary: Marty Makary is resigning as the head of the United States — Food and Drug Administration after a rocky tenure, drawing complaints from various industry executives and activists.
May 12, 2026 · 49 articles
Regulatory
Marty Makary: Marty Makary, United States — Food and Drug Administration Commissioner, co-authored the update criticizing the U.S.'s 'one-size-fits-all' approach to COVID boosters.
May 20, 2025 · 12 articles
Domestic
Marty Makary: Marty Makary, the United States — Food and Drug Administration Commissioner, appeared in the video with Robert F. Kennedy Jr., indicating support for the policy shift.
May 27, 2025 · 8 articles
Business
Marty Makary: FDA Commissioner Marty Makary, alongside Robert F. Kennedy Jr., announced steps to eliminate synthetic dyes, supporting the broader regulatory push for cleaner food ingredients.
Oct 01, 2025 · 7 articles
Regulatory
Marty Makary: As Food and Drug Commissioner, Marty Makary signaled the administration's stance on saturated fats and commented on protein guidance.
Jan 07, 2026 · 7 articles
Regulatory
Marty Makary: As the Commissioner of the United States — Food and Drug Administration, Marty Makary is a key figure in implementing the new policy to reduce the number of required studies for drug approval, aiming to speed up drug development.
Feb 18, 2026 · 6 articles
70
Marty Makary directed implementation United States — Food and Drug AdministrationFDA Launches Elsa 4.0,...
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Marty Makary interact across events, view sentiment trends, and discover connected entities.
Open Dashboard